31 related articles for article (PubMed ID: 19765233)
1. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.
Cleland JG; Abraham WT; Linde C; Gold MR; Young JB; Claude Daubert J; Sherfesee L; Wells GA; Tang AS
Eur Heart J; 2013 Dec; 34(46):3547-56. PubMed ID: 23900696
[TBL] [Abstract][Full Text] [Related]
2. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial.
Thibault B; Harel F; Ducharme A; White M; Ellenbogen KA; Frasure-Smith N; Roy D; Philippon F; Dorian P; Talajic M; Dubuc M; Guerra PG; Macle L; Rivard L; Andrade J; Khairy P;
Circulation; 2013 Feb; 127(8):873-81. PubMed ID: 23388213
[TBL] [Abstract][Full Text] [Related]
3. Optimal effectiveness of heart failure management - an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure.
Hafkamp FJ; Tio RA; Otterspoor LC; de Greef T; van Steenbergen GJ; van de Ven ART; Smits G; Post H; van Veghel D
Heart Fail Rev; 2022 Sep; 27(5):1683-1748. PubMed ID: 35239106
[TBL] [Abstract][Full Text] [Related]
4. A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure.
Tomini F; Prinzen F; van Asselt AD
Eur J Health Econ; 2016 Dec; 17(9):1159-1172. PubMed ID: 26728985
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of implantable cardioconverter defibrillator or cardiac resynchronization therapy compared with combined therapy in survival of patients with heart failure: a meta-analysis.
Deng JL; Wu YX; Liu J
Medicine (Baltimore); 2015 Feb; 94(5):e418. PubMed ID: 25654375
[TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy and QRS duration: systematic review, meta-analysis, and meta-regression.
Kang SH; Oh IY; Kang DY; Cha MJ; Cho Y; Choi EK; Hahn S; Oh S
J Korean Med Sci; 2015 Jan; 30(1):24-33. PubMed ID: 25552880
[TBL] [Abstract][Full Text] [Related]
7. Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.
Knackstedt C; Arndt M; Mischke K; Marx N; Nieman F; Kunert HJ; Schauerte P; Norra C
Heart Vessels; 2014 May; 29(3):364-74. PubMed ID: 23732755
[TBL] [Abstract][Full Text] [Related]
8. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?
Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A
Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385
[TBL] [Abstract][Full Text] [Related]
9. Cardiac resynchronization therapy: device-based medicine for heart failure.
Philippon F
J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
[TBL] [Abstract][Full Text] [Related]
10. Assessment of resynchronization therapy on functional status and quality of life in patients requiring an implantable defibrillator.
Pinter A; Mangat I; Korley V; Connolly S; Connors S; Gardner M; Philippon F; Sterns L; Thibault B; Dorian P
Pacing Clin Electrophysiol; 2009 Dec; 32(12):1509-19. PubMed ID: 19765233
[TBL] [Abstract][Full Text] [Related]
11. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
[TBL] [Abstract][Full Text] [Related]
13. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
14. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
[TBL] [Abstract][Full Text] [Related]
15. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.
Beshai JF; Grimm RA; Nagueh SF; Baker JH; Beau SL; Greenberg SM; Pires LA; Tchou PJ;
N Engl J Med; 2007 Dec; 357(24):2461-71. PubMed ID: 17986493
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
